VIORELE Drug Patent Profile
✉ Email this page to a colleague
When do Viorele patents expire, and when can generic versions of Viorele launch?
Viorele is a drug marketed by Glenmark Pharms Ltd and is included in one NDA.
The generic ingredient in VIORELE is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Viorele
A generic version of VIORELE was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12th, 1999.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VIORELE?
- What are the global sales for VIORELE?
- What is Average Wholesale Price for VIORELE?
Summary for VIORELE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Drug Prices: | Drug price information for VIORELE |
| Drug Sales Revenues: | Drug sales revenues for VIORELE |
| DailyMed Link: | VIORELE at DailyMed |
US Patents and Regulatory Information for VIORELE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharms Ltd | VIORELE | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 091346-001 | Apr 2, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
